Six Points of Miscommunication Between Oncologists and Pathologists

Slideshow

Regardless of where you practice, good communication between you and your pathologist is the best way to ensure that correct testing is done. Here are six common points of miscommunication to watch out for.

References:

1. Janne PA. What Are We Talking About: Next-Generation Sequencing, Sanger Sequencing, etc. Presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting.

2. Aisner D. Tissue is the Issue: The Pathologist’s Role in Facilitating Molecular Analysis. Presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting.

3. Nowak JA. The Practitioner's Guide to Using Molecular Testing. Presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting.

Recent Videos
Ongoing studies in kidney cancer aim to explore determinants of immune-related adverse effects and strategies for mitigating them.
Machine learning-based approaches may play a role in further understanding of how somatic alterations influence responses or resistance to therapy.
Data from a first-in-disease trial assessing a personalized cancer vaccine in RCC require validation at a larger level, according to David Braun, MD, PhD.
It can cause thrombocytopenia and diarrhea, which are generally manageable and not too big a deal.
2 KOLs are featured in this series.
Related Content